USPTO serial 79389665
XOBIOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 13, 2025
- Examiner
- MALYSZEK, KIMBERLY RAY
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XOBIOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
C. Blair Barbieri
C. Blair Barbieri Erise IP, P.A.7015 College Blvd.Suite 700Overland Park, KS 66211Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacteria, namely, cultures of microorganisms other than for medical or veterinary purposes; bacterial and bacteriological preparations, namely, cultures of microorganisms other than for medical and veterinary use; bacterial substances, namely, cultures of microorganisms for industrial and scientific use, namely, cellular extracts, extracellular vesicles and exosomes; bacteriological cultures, namely, cultures of microorganisms other than for medical and veterinary use, namely, for addition to cosmetics, skincare products, hair care products, food and beverage, and pharmaceutical products; cultures of microorganisms other than for medical or veterinary purposes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; enzyme preparations for industrial purposes, including preparations for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; probiotic bacterial formulations, namely, cultures of microorganisms other than for medical use; starter media being cell culture media for medical research use and enzymes for industrial purposes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; plant and cellular extracts being extracellular vesicles, namely, exosomes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; extracellular vesicles, namely, exosomes being cellular plant extracts for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; and raw materials being proteins and raw natural resins, and semi-finished products being chemical resins, namely, unprocessed synthetic resins and active chemical ingredients, all for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations | ACTIVE | — |
| 005 | Bacteria being cultures of microorganisms for medical or veterinary purposes; bacterial cultures being cultures of microorganisms for medical or veterinary use; bacterial preparations and products, namely, cultures of microorganisms for medical and veterinary use; biological agents being bacterial preparations, namely, cultures of microorganisms for medical purposes and for use as fungicides; biological preparations for medical, pharmaceutical, veterinary and diagnostic purposes, namely, cultures of microorganisms; nutritionally fortified beverages for medical purposes, namely, beverages containing added minerals, added trace elements and added vitamins; chemical and biochemical preparations being diagnostic reagents for medical diagnostic use; therapeutic preparations, namely, diagnostic agents, biological products in the nature of cultures of microorganisms and skin creams being for medical use; chemical products for use in detection or identification of bacteria, namely, diagnostic reagents for medical or veterinary use; cultures for medical, pharmaceutical or veterinary use, namely, cultures of microorganisms; cultures of microorganisms for medical or veterinary use for use in dietary supplements, nutritional food and beverage supplements and pharmaceutical preparations; cell culture media for medical or veterinary use; pharmaceutical and veterinary preparations for skin care; dietetic nutrients and substances for medical and veterinary use, namely, dietary supplements; dietary supplements, namely, nutritional supplements for animals and infants; dietary food preparations for medical use being medical food, namely, dietetic foods adapted for medical use; dietary food and protein supplements, namely, supplements with a cosmetic effect; diagnostic preparations for medical use and for pharmaceutical use, namely, diagnostic materials being diagnostic reagents and reagents; food supplements; herbal nutritionally fortified beverages for medicinal purposes; probiotic bacterial preparations, namely, preparations in the nature of food supplements for human consumption; probiotic bacterial formulations being dietary supplements for medical and veterinary use; medicated food supplements and nutritionally fortified beverages; medicated preparations for use as supplements for food and animal feedstuffs; medicinal nutritionally fortified beverages; nutritional supplements for human consumption and animal feed; and pharmaceutical preparations, namely, for use in treating skin and gastrointestinal disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biomecentric Pty Ltd
- Other trademarks owned by Biomecentric Pty Ltd
- Other trademarks owned by Biomecentric Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named XOBIOME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 9, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 9, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 9, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 5, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 13, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 14, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 14, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 13, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 13, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 3, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 3, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 3, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 13, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 13, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 15, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |